APS Compliance Consultants Inc.
About us
Regulatory confidence
APS are specialists in ensuring data integrity and compliance for pharmaceutical, biotech, and other GMP-regulated industries.
Focusing on Good Manufacturing Practice (GMP) environments, APS helps companies navigate complex regulatory landscapes by providing software, consulting services, and data governance solutions that streamline processes and enhance data quality.
Our services include data integrity assessment, computer system validation, Analytical Instrument qualification, and specialized software solutions designed to meet FDA 21 CFR Part 11 requirements. But what truly sets APS apart is our commitment to accelerating compliance without compromising quality. By leveraging innovative approaches, we enable clients to achieve full compliance up to 40% faster.
We deliver data you can trust—ensuring accurate, reliable, and high-quality data with a holistic approach toward equipment qualification, data integrity and software validation.
Board of directors
Kia
Kahhali
President/CEO
.jpg)
Fafa Rouhani
Director of Business Developement
Mo.
Erfani
VP of Engineering and Advanced Technology
Saeid Hashemi
VP of Marketing and Business Developement
Our Mission:
Ensuring Patient Safety Through Data Integrity
Patient safety drives industry regulations like GxP, MHRA, FDA 21 CFR Part 11, and EMEA Annex 11. Data quality and traceability are essential in drug development, manufacturing, and testing, impacting both safety and product quality.
​
Many small and medium-sized pharmaceutical companies lack the expertise in Equipment and System Qualification/Validation and Data Integrity. Our mission is to bridge this gap, guiding clients through the entire lifecycle of their systems and equipment—from selection to ongoing validation.
​
We provide expert support as a seamless extension of our clients' teams, ensuring reliable and sustainable solutions.
Trusted by Leading Brands Worldwide
Our Story
A Journey of Innovation and Excellence
APS Compliance is born from Kia Kahhali's journey—from a problem-solving engineer to a visionary leader in the pharmaceutical industry. After 20 years in the field, Kia founded APS in 2018 to offer top-tier equipment and computerized system validation services while pioneering scalable lab automation solutions. His bold vision: to democratize technology for companies of all sizes. Under his leadership, APS has become a trusted partner in the industry, continually advancing what's possible with initiatives like ALLEYE CMMS and PharmaRockIT.
Kia developed his first chromatographic software shortly before immigrating to Canada in 2005. This move marked the beginning of Kia’s journey into the world of GMP (Good Manufacturing Practice), where he would spend the next 13 years honing his skills in equipment and computer system validation, while deepening his passion for data integrity.
In 2012, Kia implemented an authentic risk-based approach to Analytical Instrument Qualification (AIQ), considering analytical instruments as systems that include their operating software. This approach, which emphasized the instrument's intended use and data integrity concerns, is notably similar to the 2017 version of USP <1058>, showcasing Kia’s deep understanding of the AIQ process and his pioneering vision.